Pregnancy outcomes in women with thyroid peroxidase antibodies.

PubWeight™: 1.64‹?› | Rank: Top 3%

🔗 View Article (PMID 20664399)

Published in Obstet Gynecol on August 01, 2010

Authors

Mina Abbassi-Ghanavati1, Brian M Casey, Catherine Y Spong, Donald D McIntire, Lisa M Halvorson, F Gary Cunningham

Author Affiliations

1: From the Department of Obstetrics and Gynecology, University of Texas Southwestern Medical Center, Dallas, Texas; and the Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, Maryland.

Articles by these authors

A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl J Med (2009) 14.40

Maternal and perinatal outcomes associated with a trial of labor after prior cesarean delivery. N Engl J Med (2004) 9.62

Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. N Engl J Med (2003) 9.57

Timing of elective repeat cesarean delivery at term and neonatal outcomes. N Engl J Med (2009) 6.86

Preventing preterm births: analysis of trends and potential reductions with interventions in 39 countries with very high human development index. Lancet (2012) 6.33

A randomized trial of prenatal versus postnatal repair of myelomeningocele. N Engl J Med (2011) 6.11

A randomized, controlled trial of magnesium sulfate for the prevention of cerebral palsy. N Engl J Med (2008) 5.11

Preventing the first cesarean delivery: summary of a joint Eunice Kennedy Shriver National Institute of Child Health and Human Development, Society for Maternal-Fetal Medicine, and American College of Obstetricians and Gynecologists Workshop. Obstet Gynecol (2012) 4.63

Subclinical hypothyroidism and pregnancy outcomes. Obstet Gynecol (2005) 4.61

Fetal pulse oximetry and cesarean delivery. N Engl J Med (2006) 4.45

Maternal morbidity associated with multiple repeat cesarean deliveries. Obstet Gynecol (2006) 3.87

Vitamins C and E to prevent complications of pregnancy-associated hypertension. N Engl J Med (2010) 3.81

The 2008 National Institute of Child Health and Human Development workshop report on electronic fetal monitoring: update on definitions, interpretation, and research guidelines. Obstet Gynecol (2008) 3.67

Pregnancy outcomes with weight gain above or below the 2009 Institute of Medicine guidelines. Obstet Gynecol (2013) 3.46

Effect of maternal body mass index on serum magnesium levels given for seizure prophylaxis. Obstet Gynecol (2013) 3.28

Decision-to-incision times and maternal and infant outcomes. Obstet Gynecol (2006) 3.15

The relationship between maternal glycemia and perinatal outcome. Obstet Gynecol (2011) 2.96

A trial of 17 alpha-hydroxyprogesterone caproate to prevent prematurity in twins. N Engl J Med (2007) 2.73

Single versus weekly courses of antenatal corticosteroids: evaluation of safety and efficacy. Am J Obstet Gynecol (2006) 2.69

Fetal injury associated with cesarean delivery. Obstet Gynecol (2006) 2.61

Proteomic identification of serum peptides predicting subsequent spontaneous preterm birth. Am J Obstet Gynecol (2010) 2.37

Selective magnesium sulfate prophylaxis for the prevention of eclampsia in women with gestational hypertension. Obstet Gynecol (2006) 2.36

Long-term outcomes after repeat doses of antenatal corticosteroids. N Engl J Med (2007) 2.30

The 2008 National Institute of Child Health and Human Development workshop report on electronic fetal monitoring: update on definitions, interpretation, and research guidelines. J Obstet Gynecol Neonatal Nurs (2008) 2.28

A randomized trial of coached versus uncoached maternal pushing during the second stage of labor. Am J Obstet Gynecol (2006) 2.27

Relationship between 17-hydroxyprogesterone caproate concentrations and gestational age at delivery in twin gestation. Am J Obstet Gynecol (2012) 2.24

Pregnancy and laboratory studies: a reference table for clinicians. Obstet Gynecol (2009) 2.24

Effect of maternal obesity on the ultrasound detection of anomalous fetuses. Obstet Gynecol (2009) 2.20

Development of a nomogram for prediction of vaginal birth after cesarean delivery. Obstet Gynecol (2007) 2.19

The obstetrical and neonatal impact of maternal opioid detoxification in pregnancy. Am J Obstet Gynecol (2013) 2.12

Advanced extrauterine pregnancy: diagnostic and therapeutic challenges. Am J Obstet Gynecol (2008) 2.08

The magnitude of hemoconcentration with eclampsia. Hypertens Pregnancy (2009) 2.04

Thyroid-stimulating hormone in singleton and twin pregnancy: importance of gestational age-specific reference ranges. Obstet Gynecol (2005) 1.99

Relationship of subclinical thyroid disease to the incidence of gestational diabetes. Obstet Gynecol (2012) 1.96

Maternal diabetes mellitus and infant malformations. Obstet Gynecol (2002) 1.84

The Maternal-Fetal Medicine Units cesarean registry: chorioamnionitis at term and its duration-relationship to outcomes. Am J Obstet Gynecol (2004) 1.75

Prediction of uterine rupture associated with attempted vaginal birth after cesarean delivery. Am J Obstet Gynecol (2008) 1.70

First-trimester prediction of preeclampsia in nulliparous women at low risk. Obstet Gynecol (2012) 1.66

Risk of uterine rupture with a trial of labor in women with multiple and single prior cesarean delivery. Obstet Gynecol (2006) 1.65

Identification of HESX1 mutations in Kallmann syndrome. Fertil Steril (2013) 1.62

Pregnancy in women with physical disabilities. Obstet Gynecol (2011) 1.60

Risk-adjusted models for adverse obstetric outcomes and variation in risk-adjusted outcomes across hospitals. Am J Obstet Gynecol (2013) 1.54

Timing of elective repeat cesarean delivery at term and maternal perioperative outcomes. Obstet Gynecol (2011) 1.54

The MFMU Cesarean Registry: factors affecting the success of trial of labor after previous cesarean delivery. Am J Obstet Gynecol (2005) 1.54

Subclinical hyperthyroidism and pregnancy outcomes. Obstet Gynecol (2006) 1.54

A prospective observational study of domestic violence during pregnancy. Obstet Gynecol (2005) 1.52

Clinical significance of borderline amniotic fluid index and oligohydramnios in preterm pregnancy. Obstet Gynecol (2011) 1.52

Ultrasonographic cervical length and risk of hemorrhage in pregnancies with placenta previa. Obstet Gynecol (2010) 1.51

17 alpha-hydroxyprogesterone caproate to prevent prematurity in nulliparas with cervical length less than 30 mm. Am J Obstet Gynecol (2012) 1.49

Emerging concepts in antibiotic prophylaxis for cesarean delivery: a systematic review. Obstet Gynecol (2009) 1.48

A randomized trial of the effects of antibiotic prophylaxis on epidural-related fever in labor. Anesth Analg (2014) 1.46

Perinatal significance of isolated maternal hypothyroxinemia identified in the first half of pregnancy. Obstet Gynecol (2007) 1.46

Glyburide in Women With Mild Gestational Diabetes: A Randomized Controlled Trial. Obstet Gynecol (2015) 1.45

Oral misoprostol for labor augmentation: a randomized controlled trial. Obstet Gynecol (2011) 1.44

Amniotic fluid index and birth weight: is there a relationship in diabetics with poor glycemic control? Am J Obstet Gynecol (2006) 1.43

A randomized controlled trial of prophylactic maneuvers to reduce head-to-body delivery time in patients at risk for shoulder dystocia. Obstet Gynecol (2003) 1.42

Prenatal treatment prevents learning deficit in Down syndrome model. PLoS One (2012) 1.41

Weekly compared with daily blood glucose monitoring in women with diet-treated gestational diabetes. Obstet Gynecol (2009) 1.41

Deus ex Makena? Obstet Gynecol (2011) 1.39

Comparison of transverse and vertical skin incision for emergency cesarean delivery. Obstet Gynecol (2010) 1.39

Hospitalization for women with arrested preterm labor: a randomized trial. Obstet Gynecol (2005) 1.38

Human myometrial gene expression before and during parturition. Biol Reprod (2004) 1.36

Thyrotoxicosis and heart failure that complicate pregnancy. Am J Obstet Gynecol (2004) 1.34

Outcomes of induction of labor after one prior cesarean. Obstet Gynecol (2007) 1.34

Prothrombin gene G20210A mutation and obstetric complications. Obstet Gynecol (2010) 1.34

The relationship of the factor V Leiden mutation and pregnancy outcomes for mother and fetus. Obstet Gynecol (2005) 1.33

Progesterone receptor polymorphisms and clinical response to 17-alpha-hydroxyprogesterone caproate. Am J Obstet Gynecol (2011) 1.28

The effect of progesterone levels and pregnancy on HIV-1 coreceptor expression. Reprod Sci (2009) 1.28

Failed operative vaginal delivery. Obstet Gynecol (2009) 1.27

Subclinical thyroid disease and the incidence of hypertension in pregnancy. Obstet Gynecol (2012) 1.25

Comparison of maternal and infant outcomes from primary cesarean delivery during the second compared with first stage of labor. Obstet Gynecol (2007) 1.24

Pharmacokinetics of 17-hydroxyprogesterone caproate in multifetal gestation. Am J Obstet Gynecol (2011) 1.24

Acute pyelonephritis in pregnancy. Obstet Gynecol (2005) 1.24

Pituitary adenylate cyclase-activating polypeptide (PACAP) mimics neuroendocrine and behavioral manifestations of stress: Evidence for PKA-mediated expression of the corticotropin-releasing hormone (CRH) gene. Brain Res Mol Brain Res (2005) 1.23

A blueprint for obstetric critical care. Am J Obstet Gynecol (2003) 1.23

Second-stage labor duration in nulliparous women: relationship to maternal and perinatal outcomes. Am J Obstet Gynecol (2009) 1.23

Clinical presentation of community-acquired methicillin-resistant Staphylococcus aureus in pregnancy. Obstet Gynecol (2005) 1.21

Obstetric antecedents for postpartum pelvic floor dysfunction. Am J Obstet Gynecol (2005) 1.21

Excessive early gestational weight gain and risk of gestational diabetes mellitus in nulliparous women. Obstet Gynecol (2012) 1.20

Labor analgesia and cesarean delivery: an individual patient meta-analysis of nulliparous women. Anesthesiology (2004) 1.18

Failed labor induction: toward an objective diagnosis. Obstet Gynecol (2011) 1.18

Presentation of seasonal influenza A in pregnancy: 2003-2004 influenza season. Obstet Gynecol (2010) 1.17

We don't know what we don't study: the case for research on medication effects in pregnancy. Am J Med Genet C Semin Med Genet (2011) 1.16

Congenital syphilis after maternal treatment for syphilis during pregnancy. Am J Obstet Gynecol (2002) 1.15

Putting the "M" back in maternal-fetal medicine. Am J Obstet Gynecol (2012) 1.14